Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis
- 1 June 2008
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 371 (9630), 2134-2143
- https://doi.org/10.1016/s0140-6736(08)60922-8
Abstract
No abstract availableFunding Information
- European Society of Cardiology
- American Heart Association
- American College of Cardiology Foundation
This publication has 90 references indexed in Scilit:
- Acute myocardial infarction and drug-eluting stents: A green light for their use or time for measured restraint?American Heart Journal, 2007
- Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarctionAmerican Heart Journal, 2007
- Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patientsInternational Journal of Cardiology, 2007
- Coronary Intervention for Persistent Occlusion after Myocardial InfarctionNew England Journal of Medicine, 2006
- Overview of Pharmacology and Clinical Trials Program with the Zotarolimus‐Eluting Endeavor StentJournal of Interventional Cardiology, 2006
- Bare metal stent restenosis is not a benign clinical entityAmerican Heart Journal, 2006
- A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery diseaseBritish Journal of Clinical Pharmacology, 2006
- A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery diseaseBritish Journal of Clinical Pharmacology, 2005
- Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulationAmerican Heart Journal, 2004
- Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placementAmerican Heart Journal, 2004